This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Learn what to look for in no fee cashback card comparisons. Make informed choices to maximize your financial benefits.
15,211 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
With volatility cooling, investors are turning to dividend-focused names. Three no-brainer high-yielding stocks with ...
General Mills sits near $39 after a soft quarter, boosting the dividend to about 6.3%. Retirees eyeing general mills’...
A veteran trader explains why dividend-heavy healthcare equities remain a bedrock in 2026 markets, drawing on two dec...
Fastly stock jumps 11% after a strong Q4 2025 report, fueling talk of a true comeback. Yet persistent insider selling...
Evernorth has filed Form S-4 as it advances a merger with Armada Acquisition Corp. II to take a Nasdaq-listed XRP tre...
Publicly traded mortgage, real estate, and homebuilder firms posted Q4 2025 results, with profits varying widely. Ana...
A new $150 million startup thinks real world connection can counter online detachment. This report examines the plan,...
Energy costs are climbing in early 2026 and are expected to ripple through U.S. supply chains, pressuring prices on g...
Hims & Hers is weighing a bold strategy that could change how obesity treatment is sold. A new partnership and drug l...
Markets swing and fear spreads fast. This guide breaks down what happens your investments in a crash, how different a...
Warren Buffett recalibrates how he donates, moving away from a single grand plan toward annual gifts routed through h...